Eterna Therapeutics
ERNA
C$2.46
Share price
-5.79%
Change (1 day)
-1.68%
Change (1 year)
Categories
Eterna Therapeutics (ERNA) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$15.15 Million
According to Eterna Therapeutics's latest financial reports the company's total liabilities are C$15.15 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Eterna Therapeutics - Total liabilities on balance sheet (from 2020 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$5.12 M | -91.77% |
| 2023-12-31 | C$62.2 M | 350.66% |
| 2022-12-31 | C$13.8 M | 79.88% |
| 2021-12-31 | C$7.67 M | 14.69% |
| 2020-12-31 | C$6.69 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | C$19.62 B | 129,339.55% | 🇺🇸 USA |
 Geron GERN | C$0.40 B | 2,572.47% | 🇺🇸 USA |
 Omeros Corporation OMER | C$0.61 B | 3,975.88% | 🇺🇸 USA |
 Sanofi SNY | C$85.61 B | 564,714.24% | 🇫🇷 France |
 Bio-Techne TECH | C$0.86 B | 5,588.38% | 🇺🇸 USA |
 Genetic Technologies GENE | C$4.01 M | -73.52% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | C$44.26 B | 291,897.46% | 🇮🇱 Israel |